Table II.
Responses of CRT and FP.
| Responses | CR | PR | SD | PD | n | P-value |
|---|---|---|---|---|---|---|
| CRT | ||||||
| NLR>3 | 0 | 11 (19.3%) | 18 (31.6%) | 28 (49.1)a | 57 | <0.05 |
| NLR≤3 | 1 (1.9%) | 29 (54.7%)a | 15 (28.3%) | 8 (15.1%) | 53 | |
| FP | ||||||
| NLR>3 | 0 | 8 (13.1%) | 24 (39.3%) | 29 (47.6%)a | 61 | <0.05 |
| NLR≤3 | 0 | 35 (39.3%)a | 37 (41.6%) | 17 (19.1%) | 89 |
Judged by RECIST criteria. CRT, chemoradiation therapy; FP, 5-fluorouracil and cisplatin; CR, complete remission; PR, partial remission; SD, stable disease; PD, progressive disease; NLR, neutrophil-to-lymphocyte ratio.
a
P<0.05.